Proceedings of the immune thrombocytopenia summit: new concepts in mechanisms, diagnosis, and management

Rilzabrutinib, an Oral BTK Inhibitor, in Immune Thrombocytopenia

(2022) David J. Kuter et al.   NEW ENGLAND JOURNAL OF MEDICINE

Thrombocytopenia following Pfizer and Moderna SARS‐CoV ‐2 vaccination

(2021) Eun‐Ju Lee et al.   AMERICAN JOURNAL OF HEMATOLOGY

Misdiagnosed thrombocytopenia in children and adolescents: analysis of the Pediatric and Adult Registry on Chronic ITP

(2021) Alexandra Schifferli et al.   Blood Advances

Platelet MHC Class I Mediates CD8+ T Cell Suppression During Sepsis

(2021) Li Guo et al.   BLOOD

Platelet features allow to differentiate immune thrombocytopenia from inherited thrombocytopenia

(2021) Guillaume Bonnard et al.   ANNALS OF HEMATOLOGY

Platelet EVs contain an active proteasome involved in protein processing for antigen presentation via MHC-I molecules

(2021) Genevieve Marcoux et al.   BLOOD

Safety of anti‐SARS‐CoV‐2 vaccination for patients with immune thrombocytopenia

(2021) Etienne Crickx et al.   BRITISH JOURNAL OF HAEMATOLOGY

Exacerbation of immune thrombocytopenia following COVID‐19 vaccination

(2021) David J. Kuter   BRITISH JOURNAL OF HAEMATOLOGY

Performance characteristics of platelet autoantibody testing for the diagnosis of immune thrombocytopenia using strict clinical criteria

(2021) Caroline Gabe et al.   BRITISH JOURNAL OF HAEMATOLOGY

Mycophenolate Mofetil for First-Line Treatment of Immune Thrombocytopenia

(2021) Charlotte A. Bradbury et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months

(2021) Stephen J. Thomas et al.   NEW ENGLAND JOURNAL OF MEDICINE

Platelet Variability Index: A measure of platelet count fluctuations in patients with immune thrombocytopenia

(2021) Na Li et al.   Blood Advances

SARS-CoV-2 Vaccination and Immune Thrombocytopenia in de novo and pre-existing ITP patients

(2021) Eun-Ju Lee et al.   BLOOD

Anti‐platelet antibody immunoassays in childhood immune thrombocytopenia: a systematic review

(2020) David E. Schmidt et al.   VOX SANGUINIS

Treatment-free remission after thrombopoietin receptor agonist discontinuation in patients with newly diagnosed immune thrombocytopenia: an observational retrospective analysis in real-world clinical practice

(2020) Masaki Iino et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

High Content, Label‐Free Analysis of Proplatelet Production from Megakaryocytes

(2020) Shauna L. French et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Platelet autoantibodies in the bone marrow of patients with immune thrombocytopenia

(2020) Sabrina Shrestha et al.   Blood Advances

Evolution and Utility of Antiplatelet Autoantibody Testing in Patients with Immune Thrombocytopenia

(2020) Leendert Porcelijn et al.   TRANSFUSION MEDICINE REVIEWS

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

(2020) Lindsey R. Baden et al.   NEW ENGLAND JOURNAL OF MEDICINE

The sensitivity and specificity of platelet autoantibody testing in immune thrombocytopenia: a systematic review and meta‐analysis of a diagnostic test

(2019) John R. Vrbensky et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Long‐term fostamatinib treatment of adults with immune thrombocytopenia during the phase 3 clinical trial program

(2019) James B. Bussel et al.   AMERICAN JOURNAL OF HEMATOLOGY

Splenectomy for immune thrombocytopenia: down but not out

(2018) Shruti Chaturvedi et al.   BLOOD

Detection of platelet autoantibodies to identify immune thrombocytopenia: state of the art

(2018) Leendert Porcelijn et al.   BRITISH JOURNAL OF HAEMATOLOGY

High-dose dexamethasone compared with prednisone for previously untreated primary immune thrombocytopenia: a systematic review and meta-analysis

(2016) Siraj Mithoowani et al.   Lancet Haematology

Novel mechanisms of platelet clearance and thrombopoietin regulation

(2015) Renata Grozovsky et al.   CURRENT OPINION IN HEMATOLOGY

Sustained remission of chronic immune thrombocytopenia after discontinuation of treatment with thrombopoietin-receptor agonists in adults

(2015) Libor Červinek et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Can Immune Thrombocytopenia Be Cured with Medical Therapy?

(2015) Eline Prak et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Eltrombopag and high-dose dexamethasone as frontline treatment of newly diagnosed immune thrombocytopenia in adults

(2014) D. Gomez-Almaguer et al.   BLOOD

Rituximab and dexamethasone vs dexamethasone monotherapy in newly diagnosed patients with primary immune thrombocytopenia

(2013) S. Gudbrandsdottir et al.   BLOOD

Platelets Present Antigen in the Context of MHC Class I

(2012) L. M. Chapman et al.   JOURNAL OF IMMUNOLOGY

Recommendations for the implementation of platelet autoantibody testing in clinical trials of immune thrombocytopenia

(2012) D. M. ARNOLD et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Microtubule and cortical forces determine platelet size during vascular platelet production

(2012) Jonathan N Thon et al.   Nature Communications

Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia

(2010) F. Zaja et al.   BLOOD

Thrombocytopenic Syndromes Masquerading as Childhood Immune Thrombocytopenic Purpura

(2010) Nichole Bryant et al.   CLINICAL PEDIATRICS

A murine model of severe immune thrombocytopenia is induced by antibody- and CD8+ T cell-mediated responses that are differentially sensitive to therapy

(2009) L. Chow et al.   BLOOD